Chonluten 20MG per vial

Introduction

Chonluten is a peptide complex that contains amino acids that normalise the lungs and bronchial mucuos cellular function.

Chonluten is a peptide that regulates gene expression and is short in length. According to research, it is primarily active in the tissue of the lungs, with only secondary levels of activity being found in the GI tract. Chonluten's ability to regulate pulmonary mucosal function could be particularly useful in the treatment of chronic inflammatory lung illnesses including asthma, COPD, and in acute and chronic respiratory disorders of infectious and non-infectious origin, as well as for preserving the function of the respiratory system in older patients.

Chonluten has been shown to have effects on / help with :

• After pneumonia
• Chronic cardiopulmonary insufficiency
• After prolonged artificial ventilation
• Pulmonary tuberculosis in remission
• In case of respiratory distress syndrome
• Intense sports
• To maintain the function of the respiratory system in elderly
• Asthma
• Crohn’s disease and Ulcerative Colitis.

Chonluten is a short peptide bioregulator of gene expression. Research has shown it to be most active in lung tissue with secondary levels of activity in the GI tract. It regulates genes related to inflammation and antioxidant activity as well as genes involved in proliferation responses to inflammation. Regulation of pulmonary mucosal function by Chonluten may have important applications in chronic inflammatory diseases of the lung such as asthma and COPD